Director receives 347K Infleqtion options after Churchill (CCCX) ColdQuanta deal

Rhea-AI Filing Summary

Churchill Capital Corp X/Cayman director reports option grant tied to merger. Dawn Clawson Meyerriecks acquired stock options for 347,403 shares of Infleqtion, Inc. on February 13, 2026, at an exercise price of $0.00 per share. These options are fully vested and were received under a merger agreement dated September 8, 2025, in which Churchill Capital Corp X combined with ColdQuanta, Inc. and changed its name to Infleqtion, Inc. Legacy ColdQuanta stock options were automatically converted into options of Infleqtion with the same terms and conditions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meyerriecks Dawn Clawson

(Last) (First) (Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE CO 80027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Churchill Capital Corp X/Cayman [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.67	02/13/2026		A(1)		347,403		(2)	08/25/2032	Common Stock	347,403	(3)	347,403	D

Explanation of Responses:

1. Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").

2. Fully vested.

3. Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and condition.

	/s/ Jason D. Hall, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Churchill Capital Corp X (CCCX) disclose?

Churchill Capital Corp X/Cayman disclosed an option grant. Director Dawn Clawson Meyerriecks acquired stock options for 347,403 shares at a $0.00 exercise price, reflecting conversion of legacy ColdQuanta options in connection with Churchill’s merger and name change to Infleqtion, Inc.

How many options did Dawn Clawson Meyerriecks receive in the CCCX Form 4?

Meyerriecks received options for 347,403 shares. The Form 4 states these are stock options granted at a $0.00 exercise price, fully vested, and issued as a result of converting legacy ColdQuanta options into Infleqtion, Inc. options after the merger.

Was the Churchill Capital Corp X (CCCX) insider option grant fully vested?

Yes, the options reported were fully vested. A footnote explains that the stock options held by director Dawn Clawson Meyerriecks are fully vested and were automatically converted from legacy ColdQuanta options into Infleqtion, Inc. options with the same terms and conditions.

What merger is referenced in the CCCX Form 4 insider filing?

The filing references a merger with ColdQuanta, Inc. Under a September 8, 2025 merger agreement, Churchill Capital Corp X combined with ColdQuanta through two merger subsidiaries and subsequently changed its name to Infleqtion, Inc., with ColdQuanta becoming a wholly owned subsidiary.

Why did CCCX director Meyerriecks receive these Infleqtion, Inc. stock options?

The options were received due to merger-related conversion. Legacy ColdQuanta stock options were automatically converted into options of Infleqtion, Inc. with identical terms, resulting in Dawn Clawson Meyerriecks holding 347,403 fully vested options following the corporate combination.

Does the CCCX Form 4 indicate a market purchase or sale of shares?

No, it shows an option acquisition via grant/conversion. The transaction code “A” and description identify it as a grant or award acquisition of stock options, with no reported open-market buy or sell of Infleqtion, Inc. common shares.